Company Filing History:
6 out of 71 
1 out of 77 
1 out of 779 Years Active: 2005-2009
Title: The Innovative Contributions of James Whelan
Introduction
James Whelan is a notable inventor based in Madison, Connecticut, with a remarkable portfolio of eight patents. His work primarily focuses on advancements in the field of pharmacology, particularly in the treatment of metabolic disorders such as type 2 diabetes.
Latest Patents
Among his latest patents is a groundbreaking invention involving peptides that act as both GLP-1 receptor agonists and glucagon receptor antagonists. This invention provides polypeptides that serve dual functions, making them useful for treating individuals with type 2 diabetes and other metabolic disorders. The innovative nature of these peptides highlights Whelan's commitment to addressing significant health challenges.
Career Highlights
Throughout his career, James Whelan has made significant contributions to the pharmaceutical industry. He has worked with prominent companies such as Bayer Pharmaceuticals Corporation and Bayer Healthcare Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to impactful inventions.
Collaborations
Whelan has collaborated with talented individuals in his field, including coworkers Clark Qun Pan and Kevin B Clairmont. These collaborations have likely enriched his work and contributed to the success of his inventions.
Conclusion
James Whelan's contributions to the field of pharmacology through his innovative patents demonstrate his dedication to improving health outcomes for individuals with metabolic disorders. His work continues to inspire advancements in medical science.